Evidence map›Paper›PMID 41398907›Full record

ArticleBMC geriatrics2025

Altered serum short-chain fatty acids in sarcopenia among Chinese elderly women: a case-control study.

Zhengyuan Wang, Zehuan Shi, Qi Song, Wei Lu, Zhuo Sun, Jiajie Zang, Chong Shao

Abstract read
In one paragraph

Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhengyuan WangDepartment of Nutrition and Health, Division of Health Risk Factors Monitoring and Control, Shanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Prevention Medicine), Shanghai, 201107, China.
Zehuan ShiDepartment of Nutrition and Health, Division of Health Risk Factors Monitoring and Control, Shanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Prevention Medicine), Shanghai, 201107, China.
Qi SongDepartment of Nutrition and Health, Division of Health Risk Factors Monitoring and Control, Shanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Prevention Medicine), Shanghai, 201107, China.
Wei LuDepartment of Nutrition and Health, Division of Health Risk Factors Monitoring and Control, Shanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Prevention Medicine), Shanghai, 201107, China.
Zhuo SunDepartment of Nutrition and Health, Division of Health Risk Factors Monitoring and Control, Shanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Prevention Medicine), Shanghai, 201107, China.
Jiajie Zang *Department of Nutrition and Health, Division of Health Risk Factors Monitoring and Control, Shanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Prevention Medicine), Shanghai, 201107, China. zangjiajie@scdc.sh.cn.
Chong Shao *Department of Rheumatology and Immunology, Shanghai Tongren Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, 200050, China. shaochong881225@163.com.

Funding

the Key Project in the Three-year Plan of Shanghai Municipal Public Health System (2023-2025) GWVI-4the Shanghai Sailing Program 23YF1437000
6 · The paper itself

Abstract

backgroundSarcopenia, characterized by the progressive loss of muscle mass and function, is increasingly prevalent among the elderly in China and globally. Emerging evidence suggests that short-chain fatty acids, key metabolites produced by gut microbiota, may influence muscle health. This study aimed to investigate the association between serum short-chain fatty acids and sarcopenia in elderly Chinese women, and to explore potential metabolic biomarkers using a targeted metabolomics approach.

methodsA case-control study was conducted involving 100 community-dwelling women aged 65 to 75 years in Shanghai, with 50 diagnosed with sarcopenia and 50 age-matched healthy controls. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 criteria. Fasting blood samples were collected, and serum short-chain fatty acid levels were measured using Gas Chromatography-Mass Spectrometry. Dietary intake and demographic data were obtained through structured questionnaires and food frequency assessments. Statistical analyses, including independent sample t-tests and partial correlation analysis, were performed using SPSS version 21.0. Metabolic pathway enrichment was analyzed using MetaboAnalyst.

resultsCompared to the control group, the sarcopenia group exhibited significantly lower serum levels of propionic acid (P = 0.004) and isovaleric acid (P = 0.001). Pathway analysis identified 19 significantly enriched metabolic pathways, three of which, carbohydrate digestion and absorption, protein digestion and absorption, and degradation of aromatic compounds, were highly associated with propionic and isovaleric acids. Dietary assessment revealed that individuals with sarcopenia had lower intake of energy, total protein, and high-quality protein, but higher sodium intake (all P < 0.05).

conclusionsAltered profiles of serum short-chain fatty acids, particularly reduced propionic acid and isovaleric acid, are associated with sarcopenia in elderly women. These metabolites may serve as potential biomarkers for early identification and risk assessment. The findings highlight the relevance of gut microbiota-derived metabolites and dietary factors in sarcopenia pathophysiology and support future development of nutritional and metabolic interventions for prevention.

trial registrationThe trial protocol was filed with the Chinese Clinical Trial Registry (registration number ChiCTR2100048874) on July 19, 2021.

Indexed as

Fatty Acids, VolatileSarcopeniaAgedBiomarkersCase-Control StudiesChinaEast Asian PeopleFemaleHumansMetabolomicsBiomarkersFatty Acids, VolatileCase–control studyGut-muscle axisMetabolomicsOlder adultsSarcopeniaShort-chain fatty acids

Identifiers

PMID41398907
PMCPMC12706993

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.